Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published online before print August 11, 2005, 10.1148/radiol.2371041087
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2371041087v1
237/1/265    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patsalides, A. D.
Right arrow Articles by Wilson, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patsalides, A. D.
Right arrow Articles by Wilson, W. H.
(Radiology 2005;237:265-273.)
© RSNA, 2005

Neuroradiology

Lymphomatoid Granulomatosis: Abnormalities of the Brain at MR Imaging1

Athos D. Patsalides, MD, Gokce Atac, MD, Upendra Hedge, MD, John Janik, MD, Nicole Grant, RN, Elaine S. Jaffe, MD, Andrew Dwyer, MD, Nicholas J. Patronas, MD and Wyndham H. Wilson, MD, PhD

1 From the Department of Diagnostic Radiology, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bldg 10, Room 1C660, 9000 Rockville Pike, Bethesda, MD 20892-1182 (A.D.P., G.A., A.D., N.J.P.); Georgetown University Hospital, Washington, DC (A.D.P.); and Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Md (U.H., J.J., N.G., E.S.J., W.H.W.). From the 2001 RSNA Annual Meeting. Received June 21, 2004; revision requested August 27; revision received November 21; accepted December 30. Address correspondence to A.D.P. (e-mail: apatsalides{at}cc.nih.gov).

PURPOSE: To retrospectively evaluate the magnetic resonance (MR) imaging features of lymphomatoid granulomatosis in the brain.

MATERIALS AND METHODS: The study, including retrospective analysis of data, was approved by the institutional review board of the National Cancer Institute and complied with Health Insurance Portability and Accountability Act. All patients gave written informed consent. Thirty-one patients with pathologically confirmed lymphomatoid granulomatosis were enrolled in a natural history and treatment study at the National Institutes of Health. Twenty-five patients (median age, 50 years; range, 18–62 years; 18 men, seven women) were evaluated with MR imaging of the brain at study entry for the presence of brain lesions and enhancing characteristics. Patients with abnormal findings were reexamined at intervals ranging from 2 to 19 months, as medically indicated. Cytologic analysis and flow cytometry of cerebrospinal fluid (CSF) were performed. Statistical analysis was performed to compare neurologic and CSF findings in patients with brain MR imaging abnormalities and in patients without abnormalities. The sensitivity of brain MR imaging was compared with that of CSF studies.

RESULTS: Thirteen (52%) of 25 patients evaluated with MR imaging had a variety of brain abnormalities. Multiple focal intraparenchymal lesions, which exhibited T2 prolongation and commonly punctate or linear enhancement, were the most frequent abnormalities, and they were encountered in seven patients. The second most common finding was involvement of leptomeninges and cranial nerves, which manifested as abnormal enhancement on MR images obtained after contrast agent administration. This abnormality was seen in six patients. Involvement of dura mater was noted in another. Four patients had brain masses. Two had abnormal engorgement and intense enhancement of the choroid plexus. Most lesions resolved after treatment, but seven resulted in lacunar infarctions. Abnormal B cells were detected in the CSF with either cytologic techniques or flow cytometry in five patients.

CONCLUSION: Lymphomatoid granulomatosis has a high rate of central nervous system involvement and a variable spectrum of lesions at MR imaging. Findings in this study suggest that MR imaging is more sensitive than CSF cytologic analysis or flow cytometry for detection of central nervous system involvement from lymphomatoid granulomatosis.

© RSNA, 2005




This article has been cited by other articles:


Home page
 Arch NeurolHome page
H. Ishiura, M. Morikawa, M. Hamada, T. Watanabe, S. Kako, S. Chiba, T. Motokura, A. Hangaishi, J. Shibahara, M. Akahane, et al.
Lymphomatoid Granulomatosis Involving Central Nervous System Successfully Treated With Rituximab Alone
Arch Neurol, May 1, 2008; 65(5): 662 - 665.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
A.T.K. Kendi, A.M. McKinney, H.B. Clark, and S.A. Kieffer
A Pediatric Case of Low-Grade Lymphomatoid Granulomatosis Presenting with a Cerebellar Mass
AJNR Am. J. Neuroradiol., October 1, 2007; 28(9): 1803 - 1805.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. O. Fleming, B. M. Keegan, and J. E. Parisi
A 52-year-old man with progressive left-sided weakness and white matter disease
Neurology, August 7, 2007; 69(6): 600 - 606.
[Full Text] [PDF]